Last year Insulet Corporation announced that it would be establishing direct operations for its Omnipod System across Europe. That means that the company will be taking over the distribution, sales, marketing, training and support for the Omnipod System across Europe once its agreement with Ypsomed ends at the end of June 2018. The two companies will work closely to ensure continuity of care for Omnipod users.
In the UK, the Omnipod System is the same product as mylife OmniPod but has always been manufactured by Insulet. Current users can be assured that this transition will not affect the supply of your Omnipod products with Ypsomed continuing to operate as the point of contact during the transition period. You will be given advance notification of any changes to the ordering process to ensure continuity of care.
Shacey Petrovic is Insulet’s President and Chief Operating Officer. She says, “This is a natural step forward for Insulet, as we work to expand the reach of Omnipod to benefit more people living with insulin-dependent diabetes around the world. We have a strong leadership team in Europe with the skills and experience to support the Omnipod System We look forward to building on our existing relationships and developing new ones within the European diabetes community.”
Check this website for the latest information and updates: www.myomnipod.com/europe
News items and features like this appear in the Desang Diabetes Magazine, our free-to-receive digital journal. We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. Go to the top of this page to sign up – we just need your email address.
Open publication
